KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Lam Research (LRCX) over the last 16 years, with Q4 2025 value amounting to $6.2 billion.

  • Lam Research's Total Current Liabilities rose 1612.73% to $6.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.2 billion, marking a year-over-year increase of 1612.73%. This contributed to the annual value of $6.6 billion for FY2025, which is 5140.07% up from last year.
  • As of Q4 2025, Lam Research's Total Current Liabilities stood at $6.2 billion, which was up 1612.73% from $6.7 billion recorded in Q3 2025.
  • In the past 5 years, Lam Research's Total Current Liabilities ranged from a high of $6.7 billion in Q3 2025 and a low of $3.4 billion during Q3 2021
  • For the 5-year period, Lam Research's Total Current Liabilities averaged around $4.7 billion, with its median value being $4.4 billion (2023).
  • In the last 5 years, Lam Research's Total Current Liabilities skyrocketed by 7155.34% in 2021 and then plummeted by 1595.38% in 2023.
  • Lam Research's Total Current Liabilities (Quarter) stood at $3.9 billion in 2021, then increased by 17.7% to $4.5 billion in 2022, then decreased by 6.04% to $4.3 billion in 2023, then rose by 25.23% to $5.4 billion in 2024, then increased by 16.13% to $6.2 billion in 2025.
  • Its Total Current Liabilities was $6.2 billion in Q4 2025, compared to $6.7 billion in Q3 2025 and $6.6 billion in Q2 2025.